Heart Risk 6 Scale in Emergency Department Acute Heart Failure Patients

October 27, 2024 updated by: Basma Mahrous Mohamed, Assiut University

The Predictive Value of the HEARTRISK6 Scale in Predicting Short-Term Serious Outcomes in Emergency Department Acute Heart Failure Patients

Detect the predictive value of the HEARTRISK6 Scale in Predicting Short-Term Serious Outcomes in emergency department acute heart failure patients in Egyptian population

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

Recently, the heartrisk6 scale was introduced to predict the short-term serious outcomes in emergency department acute heart failure patients. It was created from 3 cohorts from American and Canadian population. Since the Egyptian population differ from the American and Canadian population regarding the age at presentation with cardiovascular disease, risk factors and etiology of the acute heart failure, we sought to detect the applicability of this score on our population.

Study Type

Observational

Enrollment (Estimated)

125

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Basma Mahrous Mohamed, Master student
  • Phone Number: 01019534749 01019534749
  • Email: mahrousbasma@gmail.com

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Acute heart failure

Description

Inclusion Criteria:

  • patients who have appropriate symptoms (short-ness of breath or fatigue)(<7 days duration); with clinical signs of fluid retention (pulmonary or peripheral) in the presence of an underlying abnormality of cardiac structure or function.

    • If in doubt, a beneficial response to treatment (eg, a brisk diuresis accompanied by improvement in breathlessness) will be considered.

Exclusion Criteria:

  • Patients who did not fit the definition of AHF or who were clearly too ill to be considered for discharge after 24 hours from ED:

    • 1) resting oxygen saturation <85% on room air
    • 2) heart rate >120 beats/min;
    • 3) systolic blood pressure <85 mm Hg;
    • 4) confusion, disorientation, dementia;
    • 5) primary presentation for ischemic chest pain requiring treatment or with acute ischemic ST-Tchanges on initial electrocardiogram (ECG);

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Patients will be assessed by supervised cardiology residents in emergency department, within 24 hou

Patients will be assessed for standardized clinical variables by supervised cardiology residents in emergency department, within 24 hours from ED treatment.

•Routine laboratory values will be collected, cardiac troponins and ECG.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Detect the predictive value of the heart risk 6 scale
Time Frame: 1 month
-Detect the predictive value of the HEARTRISK6 Scale in Predicting Short-Term Serious Outcomes in the emergency department acute heart failure patients.
1 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Describe the management and outcomes of ED patients with acute heart failure
Time Frame: 1
-Describe the management and outcomes of ED patients with acute heart failure, identify the various etiologies of this presentation, and characteristics and risk factors of this population.
1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Assiut University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

October 27, 2024

Primary Completion (Estimated)

October 27, 2025

Study Completion (Estimated)

October 27, 2027

Study Registration Dates

First Submitted

October 27, 2024

First Submitted That Met QC Criteria

October 27, 2024

First Posted (Actual)

October 29, 2024

Study Record Updates

Last Update Posted (Actual)

October 29, 2024

Last Update Submitted That Met QC Criteria

October 27, 2024

Last Verified

October 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Heart Risk 6 scale in HF

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe